1. Seong J, Lee IJ, Shim SJ, et al. A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in Korea. Liver Int 2009;29:147-152.
2. Lee IJ, Seong J, Shim SJ, et al. Radiotherapeutic parameters predictive of liver complications induced by liver tumor radiotherapy. Int J Radiat Oncol Biol Phys 2009;73:154-158.
3. Song T, Suh CO, Lee I, et al. The effect of respiratory motion on forward intensity modulated radiotherapy for breast cancer. Technol Cancer Res Treat 2008;7:207-215.
4. Lee IJ, Seong J, Lee CG, et al. Early Clinical Experience and Outcome of Helical Tomotherapy for Multiple Metastatic Lesions. Int J Radiat Oncol Biol Phys 2008 (Article in press).
5. 유세환, 성진실, 이익재, et al. 간종양 방사선치료 시 토모테라피 메가볼트 CT를 이용한 치료 여백 평가. 대한방사선종양학회지 2008;26:280-288.
6. 안승권, 김용배, 이익재, et al. 사지에 발병한 카포시육종의 방사선치료를 위한 물볼루스 기구의 유용성 고찰. 대한방사선종양학회지 2008;26:189-194.
7. Shim SJ, Seong J, Lee IJ, et al. Radiation-induced hepatic toxicity after radiotherapy combined with chemotherapy for hepatocellular carcinoma. Hepatol Res 2007;37:906-913.
8. Seong J, Shim SJ, Lee IJ, et al. Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy. Int J Radiat Oncol Biol Phys 2007;67:1037-1042.
9. 김주영, 이익재, 금기창, et al. Internal Mammary Lymph Node Irradiation after Breast Conservation Surgery: Radiation Pneumonitis versus Dose-Volume Histogram Parameters. 대한방사선종양학회지 2007;25:261-267.
10. 금기창, 심수정, 이익재, et al. 1998,1999년도 우리나라에서 시행된 근치적 유방 전절제술 후 방사선치료 현황 조사. 대한방사선종양학회지 2007;25:7-15.
11. 이익재, 성진실, 심수정, et al. 간세포암종의 방사선치료 시 발생하는 간독성에 대한 위험인자의 재고찰. 대한간학회지 2006;12:420-428.
12. 이익재, 성진실, 심수정, et al. 3차원입체조형방사선치료 계획 시 간종괴의 위치에 따른 최적 조사방향의 결정. 방사선방어학회지 2006;31:187-195.
13. 조재호, 김현창, 서창옥, et al. 처방선량 및 치료기법별 치료성적 분석 결과에 기반한 자궁경부암 환자의 최적 방사선치료 스케줄. 대한방사선종양학회지 2005;23:143-156.
14. Shin HS, Seong J, Kim WC, et al. Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts. Int J Radiat Oncol Biol Phys 2003;57:105-112.
15. 이용하, 박경란, 이종영, et al. 측정기에 따른 고에너지 X-선의 표면 선량 및 최대 선량 지점 고찰. 대한방사선종양학회지 2003;21:322-329.
16. Lee IJ, Park KR, Lee KK, et al. Prognostic value of vascular endothelial growth factor in Stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 2002;54:768-779.
Results of definitive radiation therapy in adenosquamous cell carcinoma of the uterine cervix
대한암학회지 33/1 :21-26,2001
병기 IB 자궁경부암에서 혈관내피세포성장인자(VEGF)의 발현이 예후에 미치는 영향
대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 19/4 :335-344,2001
Prognostic value of vascular endothelial growth factor in stage IB carcinoma of the uterine cervix
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 54/3 :768-779,2002
직장암의 근치적 절제술 후 보조 화학요법과 보조 화학방사선 병용요법
대한방사선종양학회지(journalofthekoreansocietyfortherapeuticradiologyandoncology) 20/4 :334-342,2002
Combination of external-beam irradiation and high-dose-rate brachytherapy for inoperable carcinoma of the extra-hepatic bile ducts
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 57/1 :105-112,2003
Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 57/1 :105-112,2003
측정기에 따른 고에너지 X-선의 표면 선량 및 최대 선량 지점 고찰
대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 21/4 :322-329,2003
처방선량 및 치료기법별 치료성적 분석 결과에 기반한 자궁경부암 환자의 최적 방사선치료 스케쥴
대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 23/3 :143-156,2005
담도암의 방사선치료
대한췌담도연구회 1/ :72-79,2005
간세포암종의 방사선치료 시 발생하는 간독성에 대한 위험인자의 재고찰
The Korean Journal of Hepatology(대한간학회지) 12/3 :420-428,2006
3차원입체조형방사선치료 계획 시 간종괴의 위치에 따른 최적 조사 방향의 결정
대한방사선방어학회지 31/4 :187-195,2006
Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 67/4 :1037-1042,2007
Radiation-induced hepatic toxicity after radiotherapy combined with chemotherapy for hepatocellular carcinoma
HEPATOLOGY RESEARCH 37/ :906-913,2007
Internal Mammary Lymph Node Irradiation after Breast Conservation Surgery: Radiation Pneumonitis versus Dose-Volume Histogram Parameters
대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 25/4 :261-267,2007
1998, 1999년도 우리나라에서 시행된 근치적 유방 전절제술 후 방사선치료 현황 조사
대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 25/1 :7-15,2007
The effect of respiratory motion on forward intensity modulated radiotherapy for breast cancer
Technology In Cancer Research & Treatment 7/ :207-215,2008
사지에 발병한 카포시육종의 방사선치료를 위한 물볼루스 기구의 유용성 고찰
대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 26/3 :189-194,2008
Treatment Margin Assessment using Mega-Voltage Computed Tomography of a Tomotherapy Unit in the Radiotherapy of a Liver Tumor
대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 26/4 :280-288,2008
A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in Korea
Liver International 29/ :147-152,2009
RADIOTHERAPEUTIC PARAMETERS PREDICTIVE OF LIVER COMPLICATIONS INDUCED BY LIVER TUMOR RADIOTHERAPY
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 73/1 :154-158,2009
EARLY CLINICAL EXPERIENCE AND OUTCOME OF HELICAL TOMOTHERAPY FOR MULTIPLE METASTATIC LESIONS
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 73/ :1517-1524,2009
A Comparison of Treatment Plans using Linac-Based Intensity-Modulated Radiation Therapy and Helical Tomotherapy for Maxillary Sinus Carcinoma
Technology In Cancer Research & Treatment 8/4 :257-263,2009
비소세포성 폐암으로 수술 후 방사선치료가 시행된 N2병기 환자들에서 다발 부위 종격동 림프절 전이 여부에 따른 N2병기 구분의 임상적 의미
Journal Of The Korean Society For Therapeutic Radiology And Oncology(대한방사선종양학회지) 27/3 :126-132,2009
TUMOR HETEROGENEITY OF FIGO STAGE III CARCINOMA OF THE UTERINE CERVIX
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 75/5 :1323-1328,2009
Validation of Radiation Volume by Analysis of Recurrence Pattern in Breast-conserving Treatment for Early Breast Cancer
Journal Of Breast Cancer (한국유방암학회지) 12/4 :257-264,2009
RISK FACTORS AND DOSE-EFFECT RELATIONSHIP FOR MANDIBULAR OSTEORADIONECROSIS IN ORAL AND OROPHARYNGEAL CANCER PATIENTS
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 75/4 :1084-1091,2009
신경회로망을 이용한 4차원 방사선치료에서의 조사 표적 움직임 예측
의학물리 20/3 :132-138,2009
Positional Reproducibility and Effects of a Rectal Balloon in Prostate Cancer Radiotherapy
Journal Of Korean Medical Science 24/5 :894-903,2009
A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean results
LUNG CANCER 71/1 :55-59,2011
Selection of the Optimal Radiotherapy Technique for Locally Advanced Hepatocellular Carcinoma
JAPANESE JOURNAL OF CLINICAL ONCOLOGY 41/7 :882-889,2011
Radiosensitizers in Hepatocellular Carcinoma
SEMINARS IN RADIATION ONCOLOGY 21/4 :303-311,2011
Effect of Oral Supplementation with Branched-chain Amino Acid (BCAA) during Radiotherapy in Patients with Hepatocellular Carcinoma: A Double-Blind Randomized Study
Cancer Research and Treatment 43/1 :24-31,2011
Radiotherapeutic Strategies in the Management of Hepatocellular Carcinoma
ONCOLOGY 81/Suppl :123-133,2011
Helical tomotherapy for spine oligometastases from gastrointestinal malignancies
대한방사선종양학회지 29/4 :219-227,2011
Effect of Oral Supplementation with Branched-chain Amino Acid during Radiotherapy in Patients with Hepatocellular Carcinoma: A Double-Blind Randomized Study
Cancer Research and Treatment 43/1 :24-31,2011
USEFULNESS OF POSITRON EMISSION TOMOGRAPHY WITH FLUORINE-18-FLUORODEOXYGLUCOSE IN PREDICTING TREATMENT RESPONSE IN UNRESECTABLE HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH EXTERNAL BEAM RADIOTHERAPY
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 82/3 :1172-1178,2012
Is There a Clinical Benefit to Adaptive Planning During Tomotherapy in Patients with Head and Neck Cancer at Risk for Xerostomia?
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 35/3 :261-266,2012
The significance of ICG-R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinoma
LIVER INTERNATIONAL 32/7 :1165-1171,2012
The Optimal Selection of Radiotherapy Treatment for Hepatocellular Carcinoma
GUT AND LIVER 6/2 :139-148,2012
Molecular Markers Predict Distant Metastases After Adjuvant Chemoradiation for Rectal Cancer
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 84/5 :e577-e584,2012
Tumor-infiltrating regulatory T cells delineated by upregulation of PD-1 and inhibitory receptors
CELLULAR IMMUNOLOGY 278/1-2 :76-83,2012
Long-term Survival Outcomes Following Internal Mammary Node Irradiation in Stage II-III Breast Cancer: Results of a Large Retrospective Study With 12-Year Follow-up
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 86/5 :867-872,2013
Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma
YONSEI MEDICAL JOURNAL 54/5 :1178-1185,2013
A Comparative Planning Study of Step-and-shoot IMRT versus Helical Tomotherapy in a Model Patient
JOURNAL OF THE KOREAN PHYSICAL SOCIETY 63/7 :1481-1485,2013
Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma
JOURNAL OF RADIATION RESEARCH 54/6 :1069-1077,2013
The deep inspiration breath hold technique using Abches reduces cardiac dose in patients undergoing left-sided breast irradiation
Radiation oncology journal 31/4 :217-224,2013
High-dose Versus Standard-dose Radiotherapy with Concurrent Chemotherapy in Stages II-III Esophageal Cancer
JAPANESE JOURNAL OF CLINICAL ONCOLOGY 44/6 :534-540,2014
Improved oncologic outcomes with image-guided intensity-modulated radiation therapy using helical tomotherapy in locally advanced hepatocellular carcinoma
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 140/9 :1595-1605,2014
Dose escalation using helical tomotherapy improves local control in spine metastases fromprimary hepatic malignancies
LIVER INTERNATIONAL 34/3 :462-468,2014
Inhibition of IL-17A Suppresses Enhanced-Tumor Growth in Low Dose Pre-Irradiated Tumor Beds
PLOS ONE 9/Issue 9 :e106423-,2014
Postoperative radiotherapy dose correlates with locoregional control in patients with locoregional control in patients with extra-hepatic bile duct cancer
Radiation Oncology Journal 32/1 :7-13,2014
Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma
YONSEI MEDICAL JOURNAL 55/6 :1489-1497,2014
Local control may be the key in improving treatment outcomes of esophageal squamous cell carcinoma undergoing concurrent chemoradiation
DIGESTION 90/4 :254-260,2014
Multi-institutional analysis of T3 subtypes and adjuvant radiotherapy effects in resected T3N0 non-small cell lung cancer patients
Radiation Oncology Journal 33/2 :75-82,2015
A Feasibility Study of a Tilted Head Position in Helical Tomotherapy for Fractionated Stereotactic Radiotherapy of Intracranial Malignancies
TECHNOLOGY IN CANCER RESEARCH & TREATMENT 14/4 :475-482,2015
Risk of radiation-induced pneumonitis after helical and static-port tomotherapy in lung cancer patients and experimental rats
RADIATION ONCOLOGY 10/1 :195-,2015
Clinical Benefit of Hepatic Arterial Infusion Concurrent Chemoradiotherapy in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
CANCER RESEARCH AND TREATMENT 48/1 :190-197,2016
Mechanical quality assurance using light field for linear accelerators with camera calibration
PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS 32/ :398-402,2016
Altered Biological Potential and Radioresponse of Murine Tumors in Different Microenvironments
CANCER RESEARCH AND TREATMENT 48/2 :727-737,2016
Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 Patients
CANCER RESEARCH AND TREATMENT 48/2 :583-595,2016
The Largest Known Survival Analysis of Patients with Brain Metastasis from Thyroid Cancer Based on Prognostic Groups
PLOS ONE 11/4 :e0154739-,2016
Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma
ONCOTARGET 7/26 :40756-40766,2016
High dose and compartmental target volume may improve patient outcome after radiotherapy for pelvic bone metastases from hepatocellular carcinoma
ONCOTARGET 7/33 :53921-53929,2016
Radiological-pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgery
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 31/9 :1,619-1,627,2016
Interobserver variability in gross tumor volume delineation for hepatocellular carcinoma
STRAHLENTHERAPIE UND ONKOLOGIE 192/ :714-721,2016
Optimal Adjuvant Treatment for Curatively Resected Thoracic Esophageal Squamous Cell Carcinoma: A Radiotherapy Perspective
CANCER RESEARCH AND TREATMENT 49/1 :168-177,2017
Three-dimensional analysis of patterns of locoregional recurrence after treatment in breast cancer patients: Validation of the ESTRO consensus guideline on target volume
RADIOTHERAPY AND ONCOLOGY 122/1 :24-29,2017
Clinical application of 3D-printed-step-bolus in post-totalmastectomy electron conformal therapy
ONCOTARGET 8/15 :25,660-26,558,2017
In vivo dosimetry and acute toxicity in breast cancer patients undergoing intraoperative radiotherapy as boost
Radiation Oncology Journal 35/02 :121-128,2017
Factors affecting survival after concurrent chemoradiation therapy for advanced hepatocellular carcinoma: a retrospective study
RADIATION ONCOLOGY 12/133 :1-8,2017
Meeting Highlights: The Second Consensus Conference for Breast Cancer Treatment in Korea
JOURNAL OF BREAST CANCER 20/3 :228-233,2017
Maximum surgical resection and adjuvant intensity-modulated radiotherapy with simultaneous integrated boost for skull base chordoma
ACTA NEUROCHIRURGICA 159/ :1825-1834,2017
Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer
SCIENTIFIC REPORTS 7/ :15732-,2017
Indicators and Qualitative Assessment of Lung Cancer Management by Health Insurance Review and Assessment Service (HIRA) of Korea in 2015
Tuberculosis and Respiratory Diseases 81/1 :19-28,2018
Predictors of post-treatment stenosis in cervical esophageal cancer undergoing high-dose radiotherapy
WORLD JOURNAL OF GASTROENTEROLOGY 24/7 :862-869,2018
Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective
CLINICAL BREAST CANCER 18/2 :167-178,2018
Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study
JOURNAL OF NEURO-ONCOLOGY 138/3 :667-677,2018
Treatment outcomes of radiotherapy for anaplastic thyroid cancer
Radiation Oncology Journal 36/02 :103-113,2018
The 18F-FDG PET/CT response to radiotherapy for patients with spinal metastasis correlated with the clinical outcomes
PLOS ONE 13/9 :e0204918-e0204930,2018
Mapping patterns of locoregional recurrence following contemporary treatment with radiation therapy for breast cancer: A multi-institutional validation study of the ESTRO consensus guideline on clinical target volume
RADIOTHERAPY AND ONCOLOGY 126/1 :139-147,2018
Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive Chemoradiotherapy
FRONTIERS IN ONCOLOGY 8/ :457-466,2018
Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study
JOURNAL OF NEURO-ONCOLOGY 140/2 :445-455,2018
The Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Head and Neck Cancer Patients Treated with Radiotherapy
Journal of clinical medicine 7/ :512-524,2018
Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer: A Prospective, Randomized, Open-label, Multicenter Phase 2/3 Trial
ANNALS OF SURGERY 268/2 :215-222,2018
High-dose versus standard-dose radiation therapy for cervical esophageal cancer: Retrospective single-institution study
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 41/1 :146-153,2019
Risk factors associated with locoregional failure and estimation of survival after curative resection for patients with distal bile duct cancer
SCIENTIFIC REPORTS 9/1 :5,061-,2019
Evaluation of optimal treatment planning for radiotherapy of synchronous bilateral breast cancer including regional lymph node irradiation
RADIATION ONCOLOGY 14/56 :1-8,2019
A phase II study of intraoperative radiotherapy using a low-energy x-ray source for resectable pancreatic cancer: A study protocol
BMC SURGERY 19/1 :31-,2019
A phase II study investigating the acute toxicity of targeted intraoperative radiotherapy as tumor-bed boost plus whole breast irradiation after breast-conserving surgery in Korean patients
BREAST CANCER RESEARCH AND TREATMENT 174/1 :157-163,2019
Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningioma
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 145/5 :1,351-1,360,2019
Relationship Between Sarcopenia and Prognosis in Patient With Concurrent Chemo-Radiation Therapy for Esophageal Cancer.
FRONTIERS IN ONCOLOGY 9/5 :-,2019
Lung adenocarcinoma invasiveness risk in pure ground-glass opacity lung nodules smaller than 2 cm
THORACIC AND CARDIOVASCULAR SURGEON 67/4 :321-328,2019
Radiation-Induced CXCL12 Upregulation via Histone Modification at the Promoter in the Tumor Microenvironment of Hepatocellular Carcinoma
MOLECULES AND CELLS 42/7 :530-545,2019
Patterns of local recurrence after curative resection and reconstruction for oropharyngeal and oral cancers: Implications for postoperative radiotherapy target volumes
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 41/11 :3,916-3,923,2019
Treatment Outcome after Fractionated Conformal Radiotherapy for Hepatocellular Carcinoma in Patients with Child-Pugh Classification B in Korea (KROG 16-05)
CANCER RESEARCH AND TREATMENT 51/4 :1,589-1,599,2019
Different prognosis of patients with esophageal carcinoma with M1a and regional node involvement
DIGESTIVE AND LIVER DISEASE 51/11 :1,610-1,616,2019
Radiotherapy for initial clinically positive internal mammary nodes in breast cancer
Radiation Oncology Journal 37/02 :91-100,2019
Skeletal Muscle Depletion Predicts the Prognosis of Patients With Hepatocellular Carcinoma Treated With Radiotherapy
FRONTIERS IN ONCOLOGY 9/1075 :1-10,2019
Redefining Eligibility by Analyzing Canceled Intraoperative Radiotherapy as a Boost for Patients Undergoing Breast-Conserving Treatment
ANNALS OF SURGICAL ONCOLOGY 26/13 :4,294-4,301,2019